2026 ICD-10-CM Diagnosis Code C62.90Malignant neoplasm of unspecified testis, unspecified whether descended or undescended
ICD-10-CM Codes›C00–D49›C60-C63›C62
- Billable — Valid for Submission
- Chronic Condition
C62.90 is a billable ICD-10-CM diagnosis code for malignant neoplasm of unspecified testis, unspecified whether descended or undescended. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 715 through 716, 722 through 724. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Male reproductive system cancers - testis.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Choriocarcinoma
- Embryonal carcinoma
- Germ cell tumor of testis
- Malignant germ cell tumor of testis
- Malignant granulosa cell tumor of testis
- Malignant Leydig cell tumor of testis
- Malignant neoplasm of testis
- Malignant sex cord tumor of testis
- Malignant teratoma
- Malignant teratoma of testis
- Mixed germ cell tumor
- Mixed seminoma teratoma of testis
- Non-seminomatous germ cell neoplasm of testis
- NUT carcinoma
- Paratesticular adenocarcinoma
- Paratesticular malignant neoplasm
- Polyembryoma
- Primary choriocarcinoma of testis
- Primary embryonal carcinoma of testis
- Primary malignant granulosa cell tumor of testis
- Primary malignant Leydig cell tumor of testis
- Primary malignant neoplasm of testis
- Primary malignant seminoma of testis
- Primary malignant sex cord tumor of testis
- Primary non-seminomatous germ cell neoplasm of testis
- Primary spermatocytic seminoma of testis
- Regressed malignant testicular tumor
- Seminoma
- Seminoma of testis
- Seminoma of testis, stage 1
- Seminoma of testis, stage 2
- Seminoma of testis, stage 3
- Seminoma of testis, stage 4
- Spermatocytic seminoma of testis
- Teratoma of testis
- Yolk sac tumor
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Malignant neoplasm of testis NOS
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- male - C62.90
- male - C62.90
- Carcinoma (malignant) - See Also: Neoplasm, by site, malignant;
- male - C62.90
- male - C62.90
- unspecified site - C62.90
- male - C62.90
- Choriocarcinoma - See: Neoplasm, malignant, by site;
- male - C62.90
- male - C62.90
- Teratoma (solid) - See Also: Neoplasm, uncertain behavior, by site;
- malignant - See Also: Neoplasm, malignant, by site;
- intermediate - See: Neoplasm, malignant, by site;
- unspecified site - C62.90
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Androblastoma
- malignant
- unspecified site
- male
- Arrhenoblastoma
- malignant
- unspecified site
- male
- Carcinoma(malignant)
- chorionic
- unspecified site
- male
- Carcinoma(malignant)
- Leydig cell (testis)
- unspecified site
- male
- Carcinoma(malignant)
- Sertoli cell
- unspecified site
- Carcinoma(malignant)
- Sertoli cell
- unspecified site
- male
- Choriocarcinoma
- unspecified site
- male
- Dysgerminoma
- unspecified site
- male
- Teratoma(solid)
- malignant
- intermediate
- unspecified site
- Tumor
- endodermal sinus
- unspecified site
- male
- Tumor
- Leydig cell
- malignant
- unspecified site
- male
- Tumor
- polyvesicular vitelline
- unspecified site
- male
- Tumor
- yolk sac
- unspecified site
- male
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Choriocarcinoma
a malignant metastatic form of trophoblastic tumors. unlike the hydatidiform mole, choriocarcinoma contains no chorionic villi but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (trophoblasts). it is characterized by the large amounts of chorionic gonadotropin produced. tissue origins can be determined by dna analyses: placental (fetal) origin or non-placental origin (choriocarcinoma, non-gestational).Choriocarcinoma, Non-gestational
a highly malignant choriocarcinoma derived from the non-placental origin such as the totipotent cells in the testis, the ovary, and the pineal gland. it produces high levels of chorionic gonadotropin and can metastasize widely through the bloodstream to the lungs, brain, liver, bone, and other viscera by the time of diagnosis.Seminoma
a radiosensitive, malignant neoplasm of the testis, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. there are three variants: classical (typical), the most common type; anaplastic; and spermatocytic. the classical seminoma is composed of fairly well differentiated sheets or cords of uniform polygonal or round cells (seminoma cells), each cell having abundant clear cytoplasm, distinct cell membranes, a centrally placed round nucleus, and one or more nucleoli. in the female, a grossly and histologically identical neoplasm, known as dysgerminoma, occurs. (dorland, 27th ed)
Table of NeoplasmsClinical
Patient EducationClinical
Testicular Cancer
Testicular cancer is a cancer that develops in the tissues of one or both testicles. The testicles, or testes, are part of the male reproductive system. They make male hormones and sperm. They are two egg-shaped glands inside the scrotum, a sac of loose skin that lies below the penis. You can get cancer in one or both testicles.
The full article covers:
- What is testicular cancer?
- Who is most likely to develop testicular cancer?
- What are the symptoms of testicular cancer?
- How is testicular cancer diagnosed?
- What are the treatments for testicular cancer?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert C62.90 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About C62.90Overview
Is C62.90 a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report malignant neoplasm of unspecified testis, unspecified whether descended or undescended on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does C62.90 group to?
When malignant neoplasm of unspecified testis, unspecified whether descended or undescended is the principal diagnosis on an inpatient stay, it groups to MS-DRG 715, 716, 722, 723, 724, with relative weights from 0.6117 to 2.2373 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of C62.90?
Under the General Equivalence Mappings, malignant neoplasm of unspecified testis, unspecified whether descended or undescended converts to ICD-9-CM 186.9 (malig neo testis NEC). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
